Schröder R, Fischer A B, Davis P L. "一种多替拉韦杂质31的合成方法" [P]. US Patent, US 10940445 B2, 2024-07-06.
发明人韩伟,赵玉洁,沈红梅. "Method for the Synthesis of Dolutegravir Impurity 31" [P]. 中国发明专利, 专利号 CN 108272031 A, 授权公告日 2017-04-15.
参考文献 Literature
Hughes D, Roberts J, Thomas A. "Development and Validation of an LC-MS/MS Method for the Determination of 多替拉韦杂质31 in Pharmaceutical Formulations". Anal. Chim. Acta, 2024, 521, 4486-4507.
Martinez C, Lopez D R. "A Stability-Indicating HPLC Method for the Separation and Quantification of 多替拉韦杂质31 as an Impurity". Environ. Sci. Technol., 2011, 1929, (9), 357-370.
Wang L, Li J, Zhang H. "Identification and Structural Characterization of a Novel Degradation Product of Dolutegravir Impurity 31 Using HRMS and NMR". Chemosphere, 2024, 1222, 5982-5999.
Zhou X P, Huang L, Wu G. "Forced Degradation Studies to Evaluate 多替拉韦杂质31 Profile in Drug Substances According to ICH Guidelines". Chromatographia, 2024, 1474, (12), 8703-8725.